As a member of the CSBA (Council of State Bioscience Associations), AZBio receives a monthy run down of the latest news from our nation’s capitol.
Here is the latest Washington Update from BIO and the C2Group. Continue reading
Category Archives: AZBio News
FDA Comment Request: Establishing a unique device identification system for medical devices
The Food and Drug Administration (FDA) is proposing to establish a unique device identification system to implement the requirement added to the Federal Food, Drug, and Cosmetic Act (FD&C Act) by section 226 of the Food and Drug Administration Amendments Act of 2007 (FDAAA), Section 226 of FDAAA amended the FD&C Act to add new section 519(f), which directs FDA to promulgate regulations establishing a unique device identification system for medical devices. Continue reading
Supreme Court Obamacare Ruling Fast Tracks Healthcare Issues
A Guest Post By Larry Aldrich, Executive Director, Arizona Business Coalition on HealthContinue reading
Biochemist awarded ASU’s coveted Galvin Professorship
An expert in the structural biochemistry and biophysics of membrane proteins, ASU’s Galvin Professor Petra Fromme’s research efforts and multi-institution team are revolutionizing core understanding about infectious disease and creating exciting developments in medicine and clean energy. Continue reading
Comments Needed: SBA Releases Proposed SBIR & STTR Regulations
SBIR Inside Track: SBA Releases Proposed SBIR & STTR Regulations. Open for Public Comment Until July 16, 2012Continue reading
Flagship Sails Into New Waters With Expansion Into Neuroscience Pathology Services
Flagship Biosciencs expands quantitative histopathology services into neurodegenerative disease and neurotoxicity
Stereological and classical image analysis approaches help to more accurately quantify neuropathology and model treatment efficacyContinue reading
Performing Under PDUFA: The FDA Wants to Hear From You
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the statement of work for an assessment of the Program for Enhanced Review Transparency and Communication for New Molecular Entity (NME) New Drug Applications (NDAs) and Original Biologics License Applications (BLAs) (the Program). Continue reading
Sensitive test helps improve vaccine safety
Salmonella Typhi (S. Typhi) is the causative agent of typhoid fever, a serious health threat resulting in some 22 million new cases yearly and approximately 217,000 fatalities. A number of novel vaccine candidates using live attenuated strains of Salmonella are being developed, but care must be taken to ensure the bacteria are not excreted into the environment following vaccination.Continue reading
ASU Professor earns $6.25M research award from Department of Defense
ASU professor Hao Yan, an innovator in the field of nanotechnology, has been selected to receive a five-year, $6.25 million basic research award under the Department of Defense’s (DoD) Multidisciplinary University Research Initiative (MURI) program.Continue reading
New Technology Helps Patients Suffering Joint Damage
“It’s a stroke of genius to combine tissue engineering and improved implant measurement technology,” said Jennifer Barton, head of the UA biomedical engineering department. “No one really knew what the specific loads were on these joints before this.”Continue reading